Synovus Financial’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.95M | Sell |
81,918
-1,574
| -2% | -$56.7K | 0.04% | 279 |
|
|
2025
Q1 | $2.6M | Buy |
83,492
+64,573
| +341% | +$2.01M | 0.03% | 292 |
|
|
2024
Q4 | $483K | Sell |
18,919
-85,378
| -82% | -$2.18M | 0.01% | 653 |
|
|
2024
Q3 | $2.95M | Sell |
104,297
-118,379
| -53% | -$3.35M | 0.03% | 319 |
|
|
2024
Q2 | $5.87M | Buy |
222,676
+111,918
| +101% | +$2.95M | 0.08% | 160 |
|
|
2024
Q1 | $3.36M | Buy |
110,758
+1,049
| +1% | +$31.9K | 0.04% | 257 |
|
|
2023
Q4 | $3.08M | Sell |
109,709
-10,032
| -8% | -$282K | 0.04% | 250 |
|
|
2023
Q3 | $3.25M | Buy |
119,741
+24,721
| +26% | +$671K | 0.04% | 251 |
|
|
2023
Q2 | $2.92M | Sell |
95,020
-4,149
| -4% | -$128K | 0.03% | 280 |
|
|
2023
Q1 | $3.57M | Buy |
99,169
+6,174
| +7% | +$222K | 0.04% | 235 |
|
|
2022
Q4 | $3.68M | Buy |
92,995
+1,566
| +2% | +$61.9K | 0.04% | 229 |
|
|
2022
Q3 | $3.68M | Buy |
91,429
+1,717
| +2% | +$69K | 0.05% | 209 |
|
|
2022
Q2 | $3.77M | Buy |
89,712
+8,663
| +11% | +$364K | 0.04% | 213 |
|
|
2022
Q1 | $3.16M | Sell |
81,049
-2,801
| -3% | -$109K | 0.03% | 253 |
|
|
2021
Q4 | $3.34M | Buy |
+83,850
| New | +$3.34M | 0.03% | 251 |
|